Bristol Myers (BMY) Director Peter Arduini Receives Stock Award

What Happened
Peter J. Arduini, a director of Bristol Myers Squibb (BMY), was granted 577.082 deferred share units on 2026-03-31. The units were valued at $60.65 each, for a total grant value of $35,000. This was an award (derivative) under the company’s non-employee director deferred compensation plan, not an open-market purchase.

Key Details

• Transaction date and type: 2026-03-31 — Award/Acquisition of deferred share units (Code A).
• Price/value: 577.082 units × $60.65 = $35,000 (value reported).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes:
  • F1 — Deferred Share Units convert into common stock upon settlement; units become settleable when the director leaves the board or at a future date designated by the director.
  • F2 — Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
• Timeliness: Filing was submitted 2026-04-02 for a 2026-03-31 grant (filed within the standard Form 4 reporting window).

Context
This was a compensation award (deferred share units) typical for non-employee directors; the units are a derivative that will convert to actual shares only upon settlement. Such awards reflect routine director compensation and are not the same as an outright market purchase or sale.